Unresolved disorder model. using A ATOM 41 CA AGLN 6 5.358 -32.938 -3.909 0.50 20.75 C Unresolved disorder model. using A ATOM 42 CA BGLN 6 5.337 -32.953 -3.855 0.50 21.78 C Unresolved disorder model. using A ATOM 45 CB AGLN 6 5.316 -32.438 -5.352 0.50 20.31 C Unresolved disorder model. using A ATOM 46 CB BGLN 6 5.121 -32.482 -5.280 0.50 21.95 C Unresolved disorder model. using A ATOM 47 CG AGLN 6 5.481 -33.609 -6.382 0.50 19.69 C Unresolved disorder model. using A ATOM 48 CG BGLN 6 4.976 -33.637 -6.254 0.50 26.69 C Unresolved disorder model. using A ATOM 49 CD AGLN 6 4.258 -34.517 -6.411 0.50 21.67 C Unresolved disorder model. using A ATOM 50 CD BGLN 6 3.827 -33.415 -7.211 0.50 30.55 C Unresolved disorder model. using A ATOM 51 OE1AGLN 6 4.377 -35.757 -6.371 0.50 21.66 O Unresolved disorder model. using A ATOM 52 OE1BGLN 6 3.027 -32.515 -7.018 0.50 38.75 O Unresolved disorder model. using A ATOM 53 NE2AGLN 6 3.070 -33.900 -6.531 0.50 14.65 N Unresolved disorder model. using A ATOM 54 NE2BGLN 6 3.731 -34.248 -8.231 0.50 35.90 N Unresolved disorder model. using A ATOM 159 N AVAL 21 9.535 -31.062 -3.367 0.50 19.99 N Unresolved disorder model. using A ATOM 160 N BVAL 21 9.575 -31.036 -3.395 0.50 19.22 N Unresolved disorder model. using A ATOM 161 CA AVAL 21 9.354 -29.696 -3.902 0.50 19.65 C Unresolved disorder model. using A ATOM 162 CA BVAL 21 9.499 -29.649 -3.906 0.50 17.72 C Unresolved disorder model. using A ATOM 163 C AVAL 21 8.205 -28.986 -3.212 0.50 19.65 C Unresolved disorder model. using A ATOM 164 C BVAL 21 8.252 -28.970 -3.305 0.50 18.79 C Unresolved disorder model. using A ATOM 165 O AVAL 21 7.097 -29.545 -3.049 0.50 19.17 O Unresolved disorder model. using A ATOM 166 O BVAL 21 7.149 -29.568 -3.219 0.50 18.58 O Unresolved disorder model. using A ATOM 167 CB AVAL 21 8.954 -29.705 -5.375 0.50 19.85 C Unresolved disorder model. using A ATOM 168 CB BVAL 21 9.493 -29.627 -5.456 0.50 17.58 C Unresolved disorder model. using A ATOM 169 CG1AVAL 21 8.834 -28.236 -5.885 0.50 20.17 C Unresolved disorder model. using A ATOM 170 CG1BVAL 21 8.292 -30.397 -5.980 0.50 14.37 C Unresolved disorder model. using A ATOM 171 CG2AVAL 21 9.955 -30.478 -6.186 0.50 19.10 C Unresolved disorder model. using A ATOM 172 CG2BVAL 21 9.483 -28.162 -6.022 0.50 15.08 C Unresolved disorder model. using A ATOM 240 CA AGLU 31 18.926 -36.575 -0.484 0.50 20.04 C Unresolved disorder model. using A ATOM 241 CA BGLU 31 18.924 -36.569 -0.503 0.50 19.69 C Unresolved disorder model. using A ATOM 244 CB AGLU 31 18.471 -37.116 0.913 0.50 20.74 C Unresolved disorder model. using A ATOM 245 CB BGLU 31 18.371 -37.174 0.784 0.50 20.22 C Unresolved disorder model. using A ATOM 246 CG AGLU 31 17.294 -38.141 0.921 0.50 20.98 C Unresolved disorder model. using A ATOM 247 CG BGLU 31 18.123 -36.202 1.918 0.50 18.57 C Unresolved disorder model. using A ATOM 248 CD AGLU 31 17.007 -38.926 2.280 0.50 24.31 C Unresolved disorder model. using A ATOM 249 CD BGLU 31 19.395 -35.543 2.470 0.50 21.00 C Unresolved disorder model. using A ATOM 250 OE1AGLU 31 17.410 -38.629 3.449 0.50 17.33 O Unresolved disorder model. using A ATOM 251 OE1BGLU 31 20.525 -36.028 2.220 0.50 23.63 O Unresolved disorder model. using A ATOM 252 OE2AGLU 31 16.292 -39.932 2.172 0.50 26.75 O Unresolved disorder model. using A ATOM 253 OE2BGLU 31 19.241 -34.529 3.158 0.50 20.42 O Unresolved disorder model. using A ATOM 371 CA ALYS 47 13.338 -34.436 8.375 0.50 15.76 C Unresolved disorder model. using A ATOM 372 CA BLYS 47 13.318 -34.401 8.455 0.50 16.29 C Unresolved disorder model. using A ATOM 375 CB ALYS 47 14.426 -34.901 7.387 0.50 13.56 C Unresolved disorder model. using A ATOM 376 CB BLYS 47 14.609 -34.800 7.712 0.50 16.51 C Unresolved disorder model. using A ATOM 377 CG ALYS 47 15.303 -36.022 7.990 0.50 15.26 C Unresolved disorder model. using A ATOM 378 CG BLYS 47 15.499 -35.659 8.657 0.50 17.04 C Unresolved disorder model. using A ATOM 379 CD ALYS 47 16.673 -36.037 7.317 0.50 13.04 C Unresolved disorder model. using A ATOM 380 CD BLYS 47 16.785 -36.200 7.994 0.50 21.04 C Unresolved disorder model. using A ATOM 381 CE ALYS 47 16.650 -36.840 6.104 0.50 13.69 C Unresolved disorder model. using A ATOM 382 CE BLYS 47 17.736 -35.067 7.644 0.50 27.05 C Unresolved disorder model. using A ATOM 383 NZ ALYS 47 18.040 -36.941 5.572 0.50 20.15 N Unresolved disorder model. using A ATOM 384 NZ BLYS 47 18.911 -35.591 6.858 0.50 28.49 N Unresolved disorder model. using A ATOM 458 CA AVAL 57 2.420 -34.210 0.696 0.50 23.10 C Unresolved disorder model. using A ATOM 459 CA BVAL 57 2.438 -34.261 0.742 0.50 21.59 C Unresolved disorder model. using A ATOM 462 CB AVAL 57 3.539 -35.070 1.279 0.50 23.26 C Unresolved disorder model. using A ATOM 463 CB BVAL 57 3.400 -35.200 1.448 0.50 21.27 C Unresolved disorder model. using A ATOM 464 CG1AVAL 57 4.474 -34.234 2.098 0.50 25.57 C Unresolved disorder model. using A ATOM 465 CG1BVAL 57 4.532 -35.676 0.484 0.50 14.42 C Unresolved disorder model. using A ATOM 466 CG2AVAL 57 2.979 -36.228 2.055 0.50 24.44 C Unresolved disorder model. using A ATOM 467 CG2BVAL 57 3.978 -34.483 2.653 0.50 23.05 C Unresolved disorder model. using A ATOM 468 N AHIS 58 2.047 -34.710 -1.568 0.60 21.27 N Unresolved disorder model. using A ATOM 469 N BHIS 58 2.048 -34.681 -1.568 0.40 21.59 N Unresolved disorder model. using A ATOM 470 CA AHIS 58 1.596 -35.562 -2.651 0.60 24.06 C Unresolved disorder model. using A ATOM 471 CA BHIS 58 1.604 -35.443 -2.723 0.40 23.54 C Unresolved disorder model. using A ATOM 472 C AHIS 58 2.708 -36.536 -2.893 0.60 24.21 C Unresolved disorder model. using A ATOM 473 C BHIS 58 2.697 -36.520 -2.921 0.40 23.85 C Unresolved disorder model. using A ATOM 474 O AHIS 58 3.829 -36.122 -3.272 0.60 25.03 O Unresolved disorder model. using A ATOM 475 O BHIS 58 3.826 -36.153 -3.289 0.40 24.50 O Unresolved disorder model. using A ATOM 476 CB AHIS 58 1.288 -34.739 -3.878 0.60 23.56 C Unresolved disorder model. using A ATOM 477 CB BHIS 58 1.474 -34.486 -3.928 0.40 23.09 C Unresolved disorder model. using A ATOM 478 CG AHIS 58 0.068 -33.879 -3.706 0.60 28.34 C Unresolved disorder model. using A ATOM 479 CG BHIS 58 0.375 -33.440 -3.786 0.40 26.15 C Unresolved disorder model. using A ATOM 480 ND1AHIS 58 -1.202 -34.327 -3.998 0.60 30.19 N Unresolved disorder model. using A ATOM 481 ND1BHIS 58 0.231 -32.372 -4.655 0.40 26.39 N Unresolved disorder model. using A ATOM 482 CD2AHIS 58 -0.079 -32.625 -3.207 0.60 32.03 C Unresolved disorder model. using A ATOM 483 CD2BHIS 58 -0.617 -33.301 -2.868 0.40 29.39 C Unresolved disorder model. using A ATOM 484 CE1AHIS 58 -2.082 -33.373 -3.721 0.60 35.85 C Unresolved disorder model. using A ATOM 485 CE1BHIS 58 -0.810 -31.638 -4.297 0.40 28.41 C Unresolved disorder model. using A ATOM 486 NE2AHIS 58 -1.430 -32.333 -3.229 0.60 33.89 N Unresolved disorder model. using A ATOM 487 NE2BHIS 58 -1.341 -32.175 -3.209 0.40 28.76 N Unresolved disorder model. using A ATOM 489 CA ATHR 59 3.435 -38.875 -2.677 0.50 23.37 C Unresolved disorder model. using A ATOM 490 CA BTHR 59 3.431 -38.838 -2.658 0.50 23.91 C Unresolved disorder model. using A ATOM 493 CB ATHR 59 3.010 -40.250 -2.012 0.50 24.87 C Unresolved disorder model. using A ATOM 494 CB BTHR 59 2.940 -40.054 -1.821 0.50 25.54 C Unresolved disorder model. using A ATOM 495 OG1ATHR 59 1.728 -40.650 -2.488 0.50 23.57 O Unresolved disorder model. using A ATOM 496 OG1BTHR 59 2.258 -39.572 -0.652 0.50 27.30 O Unresolved disorder model. using A ATOM 497 CG2ATHR 59 3.012 -40.230 -0.457 0.50 25.84 C Unresolved disorder model. using A ATOM 498 CG2BTHR 59 4.085 -40.940 -1.362 0.50 26.90 C Unresolved disorder model. using A ATOM 557 N ATHR 68 3.152 -48.627 5.137 0.60 24.82 N Unresolved disorder model. using A ATOM 558 N BTHR 68 3.259 -48.654 5.127 0.40 24.27 N Unresolved disorder model. using A ATOM 559 CA ATHR 68 2.672 -48.304 6.495 0.60 26.11 C Unresolved disorder model. using A ATOM 560 CA BTHR 68 2.835 -48.510 6.531 0.40 24.89 C Unresolved disorder model. using A ATOM 561 C ATHR 68 3.756 -47.487 7.270 0.60 24.11 C Unresolved disorder model. using A ATOM 562 C BTHR 68 3.769 -47.556 7.267 0.40 23.96 C Unresolved disorder model. using A ATOM 563 O ATHR 68 3.396 -46.696 8.125 0.60 24.32 O Unresolved disorder model. using A ATOM 564 O BTHR 68 3.343 -46.754 8.085 0.40 23.86 O Unresolved disorder model. using A ATOM 565 CB ATHR 68 2.230 -49.549 7.290 0.60 26.04 C Unresolved disorder model. using A ATOM 566 CB BTHR 68 2.834 -49.838 7.281 0.40 25.11 C Unresolved disorder model. using A ATOM 567 OG1ATHR 68 3.366 -50.427 7.420 0.60 31.12 O Unresolved disorder model. using A ATOM 568 OG1BTHR 68 2.112 -50.810 6.524 0.40 24.18 O Unresolved disorder model. using A ATOM 569 CG2ATHR 68 1.021 -50.253 6.570 0.60 23.85 C Unresolved disorder model. using A ATOM 570 CG2BTHR 68 2.170 -49.679 8.657 0.40 23.81 C Unresolved disorder model. using A ATOM 572 CA ATHR 69 6.074 -46.850 7.581 0.50 21.96 C Unresolved disorder model. using A ATOM 573 CA BTHR 69 6.056 -46.838 7.603 0.50 23.97 C Unresolved disorder model. using A ATOM 576 CB ATHR 69 7.484 -47.342 7.230 0.50 22.62 C Unresolved disorder model. using A ATOM 577 CB BTHR 69 7.495 -47.321 7.328 0.50 24.81 C Unresolved disorder model. using A ATOM 578 OG1ATHR 69 7.576 -48.767 7.404 0.50 22.83 O Unresolved disorder model. using A ATOM 579 OG1BTHR 69 7.651 -47.530 5.920 0.50 30.62 O Unresolved disorder model. using A ATOM 580 CG2ATHR 69 8.538 -46.623 8.048 0.50 18.40 C Unresolved disorder model. using A ATOM 581 CG2BTHR 69 7.804 -48.639 8.038 0.50 27.81 C Unresolved disorder model. using A ATOM 660 CA ALYS 80 -1.995 -35.325 5.246 0.50 26.79 C Unresolved disorder model. using A ATOM 661 CA BLYS 80 -2.007 -35.272 5.238 0.50 27.28 C Unresolved disorder model. using A ATOM 664 CB ALYS 80 -3.103 -34.375 4.781 0.50 26.96 C Unresolved disorder model. using A ATOM 665 CB BLYS 80 -2.994 -34.188 4.764 0.50 27.40 C Unresolved disorder model. using A ATOM 666 CG ALYS 80 -4.170 -35.070 3.904 0.50 28.68 C Unresolved disorder model. using A ATOM 667 CG BLYS 80 -4.196 -33.903 5.691 0.50 31.68 C Unresolved disorder model. using A ATOM 668 CD ALYS 80 -5.085 -34.036 3.191 0.50 35.77 C Unresolved disorder model. using A ATOM 669 CD BLYS 80 -3.851 -33.452 7.115 0.50 36.76 C Unresolved disorder model. using A ATOM 670 CE ALYS 80 -6.327 -34.724 2.568 0.50 36.26 C Unresolved disorder model. using A ATOM 671 CE BLYS 80 -4.955 -33.825 8.123 0.50 39.42 C Unresolved disorder model. using A ATOM 672 NZ ALYS 80 -7.292 -35.213 3.655 0.50 36.05 N Unresolved disorder model. using A ATOM 673 NZ BLYS 80 -4.672 -35.161 8.715 0.50 38.36 N Unresolved disorder model. using A ATOM 705 CA AILE 85 -1.714 -38.047 -9.644 0.50 47.86 C Unresolved disorder model. using A ATOM 706 CA BILE 85 -1.671 -38.035 -9.658 0.50 48.98 C Unresolved disorder model. using A ATOM 709 CB AILE 85 -3.031 -38.864 -9.690 0.50 47.27 C Unresolved disorder model. using A ATOM 710 CB BILE 85 -2.858 -39.051 -9.874 0.50 48.90 C Unresolved disorder model. using A ATOM 711 CG1AILE 85 -2.836 -40.274 -9.107 0.50 44.78 C Unresolved disorder model. using A ATOM 712 CG1BILE 85 -3.926 -38.483 -10.823 0.50 50.56 C Unresolved disorder model. using A ATOM 713 CG2AILE 85 -3.567 -38.955 -11.135 0.50 47.45 C Unresolved disorder model. using A ATOM 714 CG2BILE 85 -3.506 -39.499 -8.576 0.50 50.30 C Unresolved disorder model. using A ATOM 715 CD1AILE 85 -4.139 -40.946 -8.598 0.50 39.41 C Unresolved disorder model. using A ATOM 716 CD1BILE 85 -3.607 -38.644 -12.280 0.50 52.18 C Unresolved disorder model. using A ATOM 1266 CA AGLN 155 25.856 -21.096 15.626 0.60 21.71 C Unresolved disorder model. using A ATOM 1267 CA BGLN 155 25.913 -21.091 15.534 0.40 22.23 C Unresolved disorder model. using A ATOM 1270 CB AGLN 155 25.369 -20.832 17.058 0.60 20.94 C Unresolved disorder model. using A ATOM 1271 CB BGLN 155 25.678 -20.624 16.961 0.40 22.59 C Unresolved disorder model. using A ATOM 1272 CG AGLN 155 26.300 -21.527 18.121 0.60 22.58 C Unresolved disorder model. using A ATOM 1273 CG BGLN 155 26.739 -21.120 17.913 0.40 25.85 C Unresolved disorder model. using A ATOM 1274 CD AGLN 155 27.677 -20.892 18.198 0.60 24.96 C Unresolved disorder model. using A ATOM 1275 CD BGLN 155 26.986 -20.147 19.026 0.40 28.74 C Unresolved disorder model. using A ATOM 1276 OE1AGLN 155 28.711 -21.601 18.095 0.60 27.51 O Unresolved disorder model. using A ATOM 1277 OE1BGLN 155 26.415 -19.067 19.051 0.40 36.67 O Unresolved disorder model. using A ATOM 1278 NE2AGLN 155 27.721 -19.552 18.404 0.60 16.69 N Unresolved disorder model. using A ATOM 1279 NE2BGLN 155 27.858 -20.514 19.945 0.40 33.63 N Unresolved disorder model. using A ATOM 1384 N AVAL 170 22.116 -23.757 15.048 0.60 19.71 N Unresolved disorder model. using A ATOM 1385 N BVAL 170 22.076 -23.798 15.109 0.40 18.14 N Unresolved disorder model. using A ATOM 1386 CA AVAL 170 21.021 -22.940 15.598 0.60 19.67 C Unresolved disorder model. using A ATOM 1387 CA BVAL 170 20.926 -23.058 15.645 0.40 16.59 C Unresolved disorder model. using A ATOM 1388 C AVAL 170 21.009 -21.617 14.913 0.60 19.30 C Unresolved disorder model. using A ATOM 1389 C BVAL 170 20.961 -21.642 15.079 0.40 17.68 C Unresolved disorder model. using A ATOM 1390 O AVAL 170 22.068 -20.937 14.750 0.60 19.11 O Unresolved disorder model. using A ATOM 1391 O BVAL 170 22.032 -20.971 15.068 0.40 18.08 O Unresolved disorder model. using A ATOM 1392 CB AVAL 170 21.196 -22.569 17.096 0.60 20.46 C Unresolved disorder model. using A ATOM 1393 CB BVAL 170 20.903 -23.049 17.203 0.40 15.70 C Unresolved disorder model. using A ATOM 1394 CG1AVAL 170 19.962 -21.720 17.587 0.60 20.77 C Unresolved disorder model. using A ATOM 1395 CG1BVAL 170 22.166 -22.359 17.750 0.40 13.02 C Unresolved disorder model. using A ATOM 1396 CG2AVAL 170 21.351 -23.772 17.917 0.60 22.81 C Unresolved disorder model. using A ATOM 1397 CG2BVAL 170 19.621 -22.331 17.746 0.40 14.24 C Unresolved disorder model. using A ATOM 1465 CA AGLU 180 22.251 -34.647 12.258 0.50 20.15 C Unresolved disorder model. using A ATOM 1466 CA BGLU 180 22.229 -34.648 12.278 0.50 19.53 C Unresolved disorder model. using A ATOM 1469 CB AGLU 180 22.986 -34.540 10.880 0.50 21.02 C Unresolved disorder model. using A ATOM 1470 CB BGLU 180 23.041 -34.501 10.994 0.50 20.13 C Unresolved disorder model. using A ATOM 1471 CG AGLU 180 24.441 -33.986 10.848 0.50 22.18 C Unresolved disorder model. using A ATOM 1472 CG BGLU 180 22.333 -33.831 9.789 0.50 18.23 C Unresolved disorder model. using A ATOM 1473 CD AGLU 180 25.261 -34.182 9.498 0.50 23.67 C Unresolved disorder model. using A ATOM 1474 CD BGLU 180 21.113 -34.569 9.242 0.50 22.64 C Unresolved disorder model. using A ATOM 1475 OE1AGLU 180 24.785 -34.411 8.343 0.50 18.02 O Unresolved disorder model. using A ATOM 1476 OE1BGLU 180 20.960 -35.789 9.478 0.50 22.63 O Unresolved disorder model. using A ATOM 1477 OE2AGLU 180 26.497 -34.036 9.583 0.50 25.58 O Unresolved disorder model. using A ATOM 1478 OE2BGLU 180 20.277 -33.909 8.592 0.50 22.88 O Unresolved disorder model. using A ATOM 1596 CA ALYS 196 23.164 -28.757 3.371 0.50 15.86 C Unresolved disorder model. using A ATOM 1597 CA BLYS 196 23.148 -28.720 3.291 0.50 16.34 C Unresolved disorder model. using A ATOM 1600 CB ALYS 196 22.990 -29.941 4.328 0.50 15.08 C Unresolved disorder model. using A ATOM 1601 CB BLYS 196 22.823 -30.054 3.983 0.50 17.00 C Unresolved disorder model. using A ATOM 1602 CG ALYS 196 23.610 -31.225 3.782 0.50 14.82 C Unresolved disorder model. using A ATOM 1603 CG BLYS 196 23.162 -31.233 3.044 0.50 17.04 C Unresolved disorder model. using A ATOM 1604 CD ALYS 196 22.946 -32.451 4.436 0.50 11.43 C Unresolved disorder model. using A ATOM 1605 CD BLYS 196 22.892 -32.635 3.667 0.50 18.61 C Unresolved disorder model. using A ATOM 1606 CE ALYS 196 23.615 -32.793 5.713 0.50 14.71 C Unresolved disorder model. using A ATOM 1607 CE BLYS 196 21.415 -32.850 3.954 0.50 24.95 C Unresolved disorder model. using A ATOM 1608 NZ ALYS 196 22.955 -34.036 6.172 0.50 21.59 N Unresolved disorder model. using A ATOM 1609 NZ BLYS 196 21.181 -33.931 4.992 0.50 28.86 N Unresolved disorder model. using A ATOM 1627 N AARG 200 19.459 -24.608 2.142 0.70 18.05 N Unresolved disorder model. using A ATOM 1628 N BARG 200 19.472 -24.606 2.141 0.30 18.95 N Unresolved disorder model. using A ATOM 1629 CA AARG 200 18.101 -24.581 2.615 0.70 19.58 C Unresolved disorder model. using A ATOM 1630 CA BARG 200 18.113 -24.602 2.627 0.30 19.85 C Unresolved disorder model. using A ATOM 1631 C AARG 200 17.652 -23.273 3.249 0.70 19.17 C Unresolved disorder model. using A ATOM 1632 C BARG 200 17.669 -23.278 3.232 0.30 19.51 C Unresolved disorder model. using A ATOM 1633 O AARG 200 16.418 -22.965 3.276 0.70 21.11 O Unresolved disorder model. using A ATOM 1634 O BARG 200 16.479 -22.918 3.144 0.30 20.61 O Unresolved disorder model. using A ATOM 1635 CB AARG 200 17.897 -25.738 3.622 0.70 18.85 C Unresolved disorder model. using A ATOM 1636 CB BARG 200 17.945 -25.738 3.640 0.30 19.68 C Unresolved disorder model. using A ATOM 1637 CG AARG 200 18.002 -27.118 2.873 0.70 16.88 C Unresolved disorder model. using A ATOM 1638 CG BARG 200 18.268 -27.094 3.005 0.30 19.87 C Unresolved disorder model. using A ATOM 1639 CD AARG 200 18.352 -28.392 3.783 0.70 21.02 C Unresolved disorder model. using A ATOM 1640 CD BARG 200 18.524 -28.177 4.066 0.30 22.00 C Unresolved disorder model. using A ATOM 1641 NE AARG 200 18.210 -29.583 2.934 0.70 16.39 N Unresolved disorder model. using A ATOM 1642 NE BARG 200 17.344 -28.297 4.889 0.30 20.51 N Unresolved disorder model. using A ATOM 1643 CZ AARG 200 19.051 -29.971 1.959 0.70 17.08 C Unresolved disorder model. using A ATOM 1644 CZ BARG 200 17.018 -29.359 5.625 0.30 24.72 C Unresolved disorder model. using A ATOM 1645 NH1AARG 200 20.130 -29.222 1.596 0.70 12.97 N Unresolved disorder model. using A ATOM 1646 NH1BARG 200 17.781 -30.449 5.679 0.30 17.64 N Unresolved disorder model. using A ATOM 1647 NH2AARG 200 18.738 -31.074 1.236 0.70 15.07 N Unresolved disorder model. using A ATOM 1648 NH2BARG 200 15.870 -29.326 6.305 0.30 23.14 N Unresolved disorder model. using A ATOM 1694 CA AVAL 206 28.444 -19.241 10.993 0.50 21.22 C Unresolved disorder model. using A ATOM 1695 CA BVAL 206 28.421 -19.200 11.033 0.50 22.94 C Unresolved disorder model. using A ATOM 1698 CB AVAL 206 28.771 -20.534 10.268 0.50 20.89 C Unresolved disorder model. using A ATOM 1699 CB BVAL 206 28.592 -20.593 10.419 0.50 23.05 C Unresolved disorder model. using A ATOM 1700 CG1AVAL 206 28.641 -21.770 11.226 0.50 13.05 C Unresolved disorder model. using A ATOM 1701 CG1BVAL 206 27.375 -20.998 9.644 0.50 24.25 C Unresolved disorder model. using A ATOM 1702 CG2AVAL 206 27.849 -20.704 9.089 0.50 21.77 C Unresolved disorder model. using A ATOM 1703 CG2BVAL 206 29.866 -20.718 9.608 0.50 23.30 C Unresolved disorder model. using A ATOM 1704 N AHIS 207 29.033 -19.098 13.307 0.60 21.82 N Unresolved disorder model. using A ATOM 1705 N BHIS 207 29.030 -19.124 13.315 0.40 22.95 N Unresolved disorder model. using A ATOM 1706 CA AHIS 207 29.985 -19.184 14.406 0.60 24.97 C Unresolved disorder model. using A ATOM 1707 CA BHIS 207 29.921 -19.162 14.467 0.40 25.01 C Unresolved disorder model. using A ATOM 1708 C AHIS 207 30.275 -20.648 14.626 0.60 24.67 C Unresolved disorder model. using A ATOM 1709 C BHIS 207 30.280 -20.632 14.693 0.40 24.78 C Unresolved disorder model. using A ATOM 1710 O AHIS 207 29.352 -21.438 14.908 0.60 24.90 O Unresolved disorder model. using A ATOM 1711 O BHIS 207 29.394 -21.416 15.056 0.40 24.99 O Unresolved disorder model. using A ATOM 1712 CB AHIS 207 29.460 -18.504 15.652 0.60 23.72 C Unresolved disorder model. using A ATOM 1713 CB BHIS 207 29.219 -18.545 15.676 0.40 24.71 C Unresolved disorder model. using A ATOM 1714 CG AHIS 207 29.322 -17.008 15.495 0.60 27.70 C Unresolved disorder model. using A ATOM 1715 CG BHIS 207 28.861 -17.087 15.488 0.40 27.73 C Unresolved disorder model. using A ATOM 1716 ND1AHIS 207 30.330 -16.123 15.833 0.60 29.00 N Unresolved disorder model. using A ATOM 1717 ND1BHIS 207 28.022 -16.399 16.342 0.40 30.02 N Unresolved disorder model. using A ATOM 1718 CD2AHIS 207 28.306 -16.252 15.011 0.60 28.31 C Unresolved disorder model. using A ATOM 1719 CD2BHIS 207 29.232 -16.197 14.535 0.40 30.76 C Unresolved disorder model. using A ATOM 1720 CE1AHIS 207 29.936 -14.883 15.575 0.60 33.31 C Unresolved disorder model. using A ATOM 1721 CE1BHIS 207 27.910 -15.143 15.939 0.40 30.02 C Unresolved disorder model. using A ATOM 1722 NE2AHIS 207 28.714 -14.932 15.070 0.60 31.74 N Unresolved disorder model. using A ATOM 1723 NE2BHIS 207 28.633 -14.994 14.840 0.40 30.40 N Unresolved disorder model. using A ATOM 1725 CA ATHR 208 31.963 -22.408 14.431 0.50 22.72 C Unresolved disorder model. using A ATOM 1726 CA BTHR 208 31.944 -22.379 14.415 0.50 23.77 C Unresolved disorder model. using A ATOM 1729 CB ATHR 208 33.368 -22.691 13.775 0.50 24.31 C Unresolved disorder model. using A ATOM 1730 CB BTHR 208 33.252 -22.478 13.614 0.50 25.62 C Unresolved disorder model. using A ATOM 1731 OG1ATHR 208 34.336 -21.770 14.281 0.50 22.21 O Unresolved disorder model. using A ATOM 1732 OG1BTHR 208 33.081 -21.761 12.372 0.50 28.20 O Unresolved disorder model. using A ATOM 1733 CG2ATHR 208 33.340 -22.653 12.216 0.50 25.58 C Unresolved disorder model. using A ATOM 1734 CG2BTHR 208 33.639 -23.910 13.320 0.50 27.87 C Unresolved disorder model. using A ATOM 1801 CA ATHR 218 37.542 -28.656 4.160 0.50 21.80 C Unresolved disorder model. using A ATOM 1802 CA BTHR 218 37.529 -28.640 4.120 0.50 23.41 C Unresolved disorder model. using A ATOM 1805 CB ATHR 218 37.321 -30.082 4.554 0.50 22.35 C Unresolved disorder model. using A ATOM 1806 CB BTHR 218 37.194 -30.145 4.293 0.50 23.94 C Unresolved disorder model. using A ATOM 1807 OG1ATHR 218 38.527 -30.812 4.320 0.50 23.63 O Unresolved disorder model. using A ATOM 1808 OG1BTHR 218 36.916 -30.424 5.671 0.50 29.91 O Unresolved disorder model. using A ATOM 1809 CG2ATHR 218 36.163 -30.687 3.806 0.50 18.47 C Unresolved disorder model. using A ATOM 1810 CG2BTHR 218 38.344 -31.039 3.830 0.50 26.21 C Unresolved disorder model. using A ATOM 1889 CA ALYS 229 31.543 -15.928 6.548 0.50 27.84 C Unresolved disorder model. using A ATOM 1890 CA BLYS 229 31.551 -15.937 6.542 0.50 27.59 C Unresolved disorder model. using A ATOM 1893 CB ALYS 229 31.217 -14.519 7.028 0.50 28.67 C Unresolved disorder model. using A ATOM 1894 CB BLYS 229 31.269 -14.494 6.956 0.50 28.33 C Unresolved disorder model. using A ATOM 1895 CG ALYS 229 30.596 -13.584 6.010 0.50 30.65 C Unresolved disorder model. using A ATOM 1896 CG BLYS 229 32.350 -13.842 7.858 0.50 28.92 C Unresolved disorder model. using A ATOM 1897 CD ALYS 229 31.533 -12.993 4.982 0.50 37.69 C Unresolved disorder model. using A ATOM 1898 CD BLYS 229 32.114 -12.310 7.907 0.50 35.30 C Unresolved disorder model. using A ATOM 1899 CE ALYS 229 31.558 -13.765 3.666 0.50 40.62 C Unresolved disorder model. using A ATOM 1900 CE BLYS 229 30.738 -11.921 7.397 0.50 35.03 C Unresolved disorder model. using A ATOM 1901 NZ ALYS 229 32.533 -13.097 2.767 0.50 40.64 N Unresolved disorder model. using A ATOM 1902 NZ BLYS 229 30.740 -11.362 5.988 0.50 41.64 N 1